Intended Use
Analyte Specific Reagent
Summary and Explanation
The Epstein Barr virus antibody (EBV) detects the Epstein Barr virus, it is also called Human Herpesvirus 4 (HHV-4). It is a virus of the Herpes family, and is one of the most common viruses in humans. The virus can execute many distinct programs of gene expression, which can be broadly categorized as being lytic cycle or latent cycle. The lytic cycle, or productive infection, results in staged expression of several viral proteins with the ultimate objective of producing infectious virions. The latent cycle (lysogenic) programs are those that do not result in production of virions. A very limited, distinct set of viral proteins are produced during latent cycle infection. These include Epstein-Barr nuclear antigens EBNA-1, EBNA-2, EBNA-3A, EBNA-3B, EBNA-3C, EBNA-leader protein (EBNA-LP), latent membrane proteins LMP-1, LMP-2A and LMP-2B and the Epstein-Barr encoded RNAs (EBERs). In addition, EBV codes for at least twenty microRNAs which are expressed in latently infected cells.
Presentation
EBV antibody is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Synonyms: EBV Ea D, EBV EaD, sc-58121, 58121, Epstein Barr virus, strain B95 8, anti-epstein barr virus, anti-ebv, anti ebv, HHV 4, Early antigen protein D, DNA polymerase processivity factor BMRF1, Polymerase accessory subunit
